Information and documents given to ASX become ASX's property and may be made public.
Rule 3.8A
Name of entity
Sigma Healthcare Limited
We (the entity) give ASX the following information.
Information about buy-back
ABN/ARSN 15 088 417 403
1
Type of buy-back
On-market buy-back
2
Date Appendix 3C was given to
13 September 2012
ASX
(Associated Appendix 3D dated 11 November
2016, 23 March 2017 and 6 November 2017)
Total of all shares/units bought back, or in relation to which acceptances have been received, before, and on, previous day
3 Number of shares/units bought back or if buy-back is an equal access scheme, in relation to which acceptances have been received
4 Total consideration paid payable for the shares/units
Before previous day
Previous day
129,819,352
556,644
or
$97,824,202
$485,839
Appendix 3E
Daily share buy-back notice
Before previous day
Previous day
5
If buy-back is an on-market buy-back
Highest price paid: $1.2400
Lowest price paid: $0.5600
Highest price paid: $0.8850
Lowest price paid: $0.8550
Highest price allowed under rule 7.33: $1.0033
How many shares/units may still be bought back?
6
If the company/trust has disclosed an intention to buy back a maximum number of shares/units - the remaining number of shares/units to be bought back
88,576,102
Compliance statement
1. The company is in compliance with all Corporations Act requirements relevant to this buy-back.
2. There is no information that the listing rules require to be disclosed that has not already been disclosed, or is not contained in, or attached to, this form.
or, for trusts only:
1. The trust is in compliance with all requirements of the Corporations Act as modified by Class Order 07/422, and of the trust's constitution, relevant to this buy-back.
2. There is no information that the listing rules require to be disclosed that has not already been disclosed, or is not contained in, or attached to, this form.
Sign here:
Date: 12 January 2018
(Director/Company secretary)
Print name:Sam Lawson
Sigma Healthcare Limited published this content on 12 January 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 January 2018 22:39:09 UTC.
Original documenthttp://investorcentre.sigmahealthcare.com.au/static-files/5e501c0e-8b18-466b-af4d-c5f67bd67a40
Public permalinkhttp://www.publicnow.com/view/7AF1DEAFA332CE658BF8523EB0172774A5D1B84E
Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.
SIGMA HEALTHCARE LIMITED 
